InterVene's mission is to provide the first effective and widely-utilized therapy for patients suffering from the painful and costly symptoms of Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR).

​

InterVene is a product of the Stanford Biodesign Fellowship program and is a former Company-In-Residence at the Fogarty Institute for Innovation. InterVene’s team is made up of experienced industry veterans, many of whom were early team members at companies such as Ardian, eValve, Access Closure, and Silk Road Medical. The company’s office is located in South San Francisco near SFO airport.